I am a researcher, a teacher, and a leader.

With over two decades of post-doctoral research experience, my research focuses on enabling technologies to better understand how blood platelets work in health and disease. This approach yields knowledge and tools that are of use to scientists and doctors in diagnosis, monitoring and treatment of disease. It contributes to science and medical education and is valuable to patients and their families to better understand and monitor their health.

As a teacher, I train the next generation of hospital scientists with a bespoke, accredited, work integrated postgraduate haematology and transfusion science curriculum that I developed.

My works are widely published. I am a sought-after speaker at international events in my field. I provide expert advice to governments related to research support and infrastructure. I have contributed to university leadership as departmental chair, and I hold leadership and board positions for national and international scientific certification bodies and non-profit scientific societies. 

Specialties: Cytometry, platelet biology, work integrated learning 

Matthew is Associate Professor of Haematology and Transfusion Science at The School Biomedical Sciences. He leads the development and delivery of haematology and transfusion science curriculum in the Master of Clinical Pathology, supports undergraduate teaching in the Bachelor of Science (Biomedical Sciences Major), and forms part of the School's research program in haematology and translational cancer pathology. Matthew also leads a program of research which focuses on the role of platelets biology and function in health and disease.

2024 WA Dept Health (CIB) $100,000
2024 Telethon Foundation (CIB) $190,000
2024 International Council on Standardisation in Haematology (CIA) $8,000
2024 Australian Institute of Medical and Clinical Scientists (CIA) $5,000
2023 Cancer Council WA (CIE) $120,000
2019 Perpetual Trustees IMACT (IPAP2019/0291 CIC) $300,000
2018 Ruby Red Foundation (CIC) $15,000
2018 Perpetual Trustees IMPACT (IPAP2018/1802 CIC) $81,606
2017 UWA Research Collaboration Award (CID) $29,290
2016 NHMRC Project Grant (APP1129317 CIF) $1,113,385
2016 Australian Research Council Discovery Project (DP170104832 CIC) $372,500
2014 Australian Research Council LIEF (LE150100066 CIE) $440,000
2014 WA Department of Health (CIA) $75,000
2014 Ada Bartholomew Trust (CIA) $28,471
2013 Perpetual Trustees & Ronald Geoffrey Arnott Foundation (CIA) $65,000
2013 The Ian Potter Foundation (CIA) $25,000
2013 NHMRC Equipment Allocation (CIA) $50,000
2012 Diabetes Australia Research Trust (CIA) $58,407.
2011 Helen McPherson Research Trust (CIC) $24,700.
2011 RMIT University Scheme for Teaching and Learning Research (CIC) $6,924.
2010 Carlton Football Club (CIB) $25,255.
2009 Ian Potter Foundation (CIA) $100,000.

• Co-convenor: CYTO-Connect Perth
• Board of Trustees, International Society for the Advancement of Cytometry
• Councillor and Past President, Australasian Cytometry Society - 
  
• Deputy Chair, WA Branch: Australian Institute of Medical and Clinical Scientists
• Editorial Board - Journal of Cardiovascular Pharmacology & Therapeutics
  Reviews Editor - Frontiers in Cardiovascular Biology

I am a haematology researcher with two decades of post-doctoral experience at the interface of academia and industry. My research focusing on measuring the intricate biology of blood platelets and their role in health and disease. I have developed and applied innovative molecular and cytometric tools for blood platelet measurements and systems biology. I have contributed to drug discovery and monitoring of safety and efficacy of novel platelet targeting therapies in clinical settings through clinical best practice guidelines and commercial patents.

PATH5161 - Unit Coordinator
PATH5162 - Unit Coordinator
PATH5181 - Unit Coordinator
MJD-PLMED Curriculum Team

Matthew's research focus is in the study of blood platelet biology and function. His research is advancing the understanding of molecular and functional abnormalities and response to therapy in platelets in haematological malignancies, thermal burn injury and cardiovascular disease. His work contributes both to the understanding of the disease pathology, but also provides diagnostically and prognostically useful platelet based biomarkers.